Ethanol-Mediated Regulation of Cytochrome P450 2A6 Expression in Monocytes: Role of Oxidative Stress-Mediated PKC/MEK/Nrf2 Pathway by Jin, Mengyao et al.
Ethanol-Mediated Regulation of Cytochrome P450 2A6
Expression in Monocytes: Role of Oxidative Stress-
Mediated PKC/MEK/Nrf2 Pathway
Mengyao Jin, Anil Kumar, Santosh Kumar*
Division of Pharmacology and Toxicology, School of Pharmacy, University of Missouri-Kansas City, Kansas City, Missouri, United States of America
Abstract
Cytochrome P450 2A6 (CYP2A6) is known to metabolize nicotine, the major constituent of tobacco, leading to the
production of toxic metabolites and induction of oxidative stress that result in liver damage and lung cancer. Recently, we
have shown that CYP2A6 is induced by ethanol and metabolizes nicotine into cotinine and other metabolites leading to
generation of reactive oxygen species (ROS) in U937 monocytes. However, the mechanism by which CYP2A6 is induced by
ethanol is unknown. In this study, we have examined the role of the PKC/Nrf2 pathway (protein kinase C-mediated
phosphorylation and translocation of nuclear erythroid 2-related factor 2 to the nucleus) in ethanol-mediated CYP2A6
induction. Our results showed that 100 mM ethanol significantly induced CYP2A6 mRNA and protein (,150%) and
increased ROS formation, and induction of gene expression and ROS were both completely blocked by treatment with
either a CYP2E1 inhibitor (diallyl sulfide) or an antioxidant (vitamin C). The results suggest the role of oxidative stress in the
regulation of CYP2A6 expression. Subsequently, we investigated the role of Nrf2 pathway in oxidative stress-mediated
regulation of CYP2A6 expression in U937 monocytes. Our results showed that butylated hydroxyanisole, a stabilizer of
nuclear Nrf2, increased CYP2A6 levels .200%. Staurosporine, an inhibitor of PKC, completely abolished ethanol-induced
CYP2A6 expression. Furthermore, our results showed that a specific inhibitor of mitogen-activated protein kinase kinase
(MEK) (U0126) completely abolished ethanol-mediated CYP2A6 induction and Nrf2 translocation. Overall, these results
suggest that CYP2E1-mediated oxidative stress produced as a result of ethanol metabolism translocates Nrf2 into the
nucleus through PKC/MEK pathway, resulting in the induction of CYP2A6 in monocytes. An increased level of CYP2A6 in
monocytes is expected to further increase oxidative stress in smokers through CYP2A6-mediated nicotine metabolism. Thus,
this study has clinical relevance because of the high incidence of alcohol use among smokers, especially in HIV-infected
individuals.
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Introduction
Cytochrome P450 (CYP) comprises a superfamily of heme
proteins, which are most abundant in the liver and are involved in
the metabolism of numerous xenobiotics, including the majority of
therapeutic drugs [1]. To a lesser extent, they are also found in
other organs, such as lung, brain, and kidney [2–4]. The CYP2A6
isozyme is known to metabolize nicotine, the major constituent of
tobacco, causing tobacco-associated toxicities in both the liver and
lung [5]. In addition, CYP2A6 activates multiple tobacco
procarcinogens including 4-(methylnitrosamino)-1-(3-pyridyl)-1-
butanone (NNK), leading to liver damage and lung cancer [5].
CYP2A6 is involved in approximately 3% of all CYP-mediated
metabolisms of therapeutic drugs, such as pilocarpine, cyclophos-
phamide and tegafur. Furthermore, CYP2A6 has been implicated
in drug-drug interactions in normal, as well as in polymorphic
populations [6,7].
In general, four major nuclear receptors are known to regulate
different CYP isozymes [8]. These are: 1) Aryl hydrocarbon
receptor (AhR), which is associated with the regulation of
CYP1A1, 1A2, and 1B1; 2) Constitutive androstane receptor ,
which mediates the regulation of CYP2B enzymes; 3) Peroxisome
proliferator-activated receptor (PPAR), which is associated with
CYP2C expression; and 4) Pregnane X-receptor (PXR), which is
important in regulating CYP2B and CYP3A enzymes. Although
the pathway by which many CYP enzymes are regulated is known,
the mechanism of CYP2A6 regulation is not clear. A previous
study has shown that in the presence of PPARc, the heterodimer
PXR/retinoic X receptor is involved in the regulation of CYP2A6
in hepatocytes [9].
A recent study has shown that mouse CYP2A5 (analogous to
human CYP2A6) is induced through oxidative stress resulting
from ethanol consumption and nicotine treatment [10,11].
Consistent with this, our previous study has shown that CYP2A6
is the most abundant CYP in U937 cells and is induced by ethanol
[12,13]. However, the mechanism of CYP2A6 induction by
ethanol in monocytes is not known. Monocytes/macrophages are
one of the major targets of HIV-1 infection and are also one of the
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e35505major reservoirs for virus replication [14]. U937 is a human
monocytic cell line and is utilized for HIV-1 related research [15].
The prevalence of smoking is 3 times higher in alcohol users
compared to the normal population, and the prevalence of co-
abuse is approximately 90% among HIV-1 infected individuals
[16,17]. Thus, it is important to determine the mechanism(s)
responsible for alcohol-mediated induction of CYP2A6 in
monocytes/macrophages. In the current study, we investigate
the pathway by which ethanol induces CYP2A6 in the U937
monocyte cell line.
Materials and Methods
Materials
The U937 monocytic cell line was obtained from ATCC
(Manassas, VA). Protease inhibitor cocktail, vitamin C, butylated
hydroxyanisole (BHA), staurosporine, U0126, and SB600125 were
bought from Sigma-Aldrich (St. Louis, MO). Diallyl sulfide (DAS)
was bought from Alfa Aesar, Heysham (Lancs, UK). Roswell Park
Memorial Institute (RPMI) 1640 and Dulbecco’s modified eagle
medium (DMEM) media were purchased from Mediatech Inc.
(Manassas, VA). The Qiagen RNeasy kit was obtained from
Qiagen, (Valencia, CA). Gene expression kits and primer probes
(CYP2A6, Hs0071162_m1) were obtained from Life Technologies
(Foster City, CA). Radioimmunoprecipitation assay (RIPA) buffer
was obtained from Boston BioProducts, (Ashland, MA). The
bicinchoninic acid (BCA) protein assay kit was obtained from
Thermo Scientific (Rockford, IL). All primary and secondary
antibodies were from Santa Cruz Biotechnology Inc. (Santa Cruz,
CA). Luminata
TM Crescendo western HRP substrate was
obtained from EMD Millipore Corporation (Billerica, MA). NE-
PER Nuclear and Cytoplasmic Extraction Reagents were
purchased from Thermo Scientific (Rockford, IL). Dichlorofluor-
oscein diacetate (DCFDA) was purchased from Life Technologies
(Grand Island, NY).
Cell culture and treatments
U937 cells were grown in RPMI 1640 media with 1%
gentamicin at 37uC in a humidified incubator containing 5%
CO2. Ethanol treatment of U937 monocytes was performed at
100 mM as previously described [13]. Treatments with vitamin C,
BHA, staurosporine, SB600125, and U0126 were initiated 1 h
prior to ethanol treatment. However, DAS was pretreated for
15 min, prior to ethanol treatment according to the previous
protocol [18]. For control samples, only media or appropriate
solvents for each treatment group (alcohol with and without DAS,
BHA, vitamin C, SB600125 and U0126) were used at each time
point.
RNA extraction and quantitative reverse transcriptase-
polymerase chain reaction (qRT-PCR)
Total RNA was extracted using a Qiagen RNeasy kit based on
manufacturer’s protocols. For each reaction, RNA (100 ng) from
the samples was reverse-transcribed into cDNA using the High-
capacity cDNA Reverse Transcription Kit. qRT-PCR was
performed using cDNA generated from the reverse transcription
Figure 1. Effect of CYP2E1 selective inhibitor, DAS on ethanol-induced CYP2A6 expression level and oxidative stress. (A) CYP2A6
mRNA. (B) CYP2A6 protein. Both mRNA and protein expression levels were determined at 12 h in the presence of 100 mM ethanol (2/+100 mM DAS,
15 min prior to ethanol treatment). For each experiment, the mRNA/protein levels of various treatments were normalized relative to the untreated
control, which has been set to 100%. Blots are representative of at least three replicates. (C) Representative figure of the determination of ROS levels
at 2 h ethanol treatment with 0 and 100 mM DAS pretreatment for 15 min. The events (cell population) are presented in Y-axis and relative
fluorescence intensity is presented in X-axis. (D) Bar graphs of MFI in the presence and absence of ethanol and DAS. The mean 6 SD was calculated
from at least triplicates and significance (p#0.05; *) was determined using one-way ANOVA. The experiment was repeated twice.
doi:10.1371/journal.pone.0035505.g001
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were analyzed on the iCycler iQ system (BioRad Laboratories,
Hercules, CA). Relative gene expression was calculated using b-
actin (ACTB) as an endogenous control. Ethanol treatment did not
alter ACTB gene expression significantly in our experimental
conditions in U937 monocytes (data not shown).
Western blotting
Total cell lysate was prepared using RIPA buffer, including 4%
of 16protease inhibitor cocktail. The protein concentrations were
measured using the BCA protein assay kit. Western blotting was
performed essentially as previously described [13]. Briefly, 20 mg
of total proteins were run on a SDS-PAGE and then transferred to
polyvinylidene fluoride membranes. Transferred blots were
blocked in 5% nonfat dry milk followed by overnight incubation
with primary antibody (1:1000 dilution) and 2 h incubation with
an appropriate secondary antibody (1:1500 dilution). Proteins
were detected using Luminata
TM Crescendo western HRP
substrate, and quantified using the Alpha Innotech FluorChem
HD2 gel documentation system (Proteinsimple, Santa Clara, CA).
The densitometry data were analyzed using AlphaEase FC
StandAlone software (version 6.0.0.14; Alpha Innotech). b-tubulin
served as internal loading control to normalize the expression of
CYP2A6 from whole cell extract, while lamin B was used as an
internal control for the nuclear extract.
Nuclear fractions preparation
Nuclear and cytosolic fractions were separated using NE-PER
Nuclear and Cytoplasmic Extraction Reagents, according to the
manufacturer’s protocol. Briefly, the cell pellet was resuspended in
CER I buffer and incubated on ice for 10 min followed by
centrifugation at 16,0006ga t4 uC for 5 min. The supernatant
(cytosolic fraction) was collected and stored at 280uC. The pellets
wereresuspended in NER buffer, followed by 20 min incubationon
ice. Cell debris was removed by centrifuging at 16,0006g for
10 min and the nuclear fraction in the supernatant was stored at
280uC. Nuclear fractions were used to measure Nrf2 protein levels.
ROS measurement by flow cytometry
The production of ROS was measured by flow cytometry using
DCFDA as described previously [12,13]. Briefly, the monocytes
were treated with alcohol, either with or without inhibitors, using
serum-free medium at different times in a 6-well plate followed by
addition of 10 mM DCFDA. Cells were then harvested and
resuspended in 1 ml PBS to measure the DCF emission at
525620 nm using a flow cytometer (BD Biosciences, San Jose,
CA).Mean fluorescence intensity(MFI) wasmeasured and analyzed.
Statistical analysis
Statistical analysis for qRT-PCR, western blotting, and ROS
measurement data was performed to determine mean 6 SD and p
Figure 2. Effect of vitamin C on ethanol-induced CYP2A6 expression level and CYP2E1-mediated oxidative stress. (A) CYP2A6 mRNA.
(B) CYP2A6 protein. Both mRNA and protein expression levels were determined at 12 h in the presence of 100 mM ethanol treatment (2/+100 mM
vitamin C 1 h prior to ethanol treatment). Blots are representative of at least three replicates. For each experiment, the mRNA/protein levels of various
treatments were normalized relative to the untreated control, which has been set to 100%. (C) Representative figure of the determination of ROS
levels at 2 h ethanol treatment with 0 and 100 mM vitamin C pretreatment for 1 h. The events (cell population) are presented in Y-axis and relative
fluorescence intensity is presented in X-axis. (D) Bar graphs of MFI in the presence and absence of ethanol and vitamin C. The mean 6 SD was
calculated from at least triplicates and significance (p#0.05; *) was determined using one-way ANOVA. The experiment was repeated three times.
doi:10.1371/journal.pone.0035505.g002
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significant.
Results
CYP2A6 is induced by CYP2E1-mediated ethanol
metabolism
U937 monocytes were pretreated in the absence or presence of
100 mM DAS to selectively inhibit CYP2E1 [19], followed by
ethanol treatment for 12 h. Consistent with our previous study
[13], 100 mM ethanol increased CYP2A6 mRNA and protein
expression levels to 170% and 150% relative to control,
respectively (Fig. 1A and B). As expected, DAS significantly
inhibited ethanol-mediated CYP2A6 induction at both mRNA
and protein levels. Similarly, consistent with our earlier finding
[13], ethanol increased ROS formation by 25–30%, and DAS
attenuated ethanol-induced ROS formation (Fig. 1C and D). DAS
alone did not alter CYP2A6 expression or ROS production. In
order to confirm that CYP2E1 is mainly involved in ethanol
metabolism in U937 monocytes, we measured alcohol dehydro-
genase (ADH) in monocytes. However, the level of ADH mRNA
in U937 monocytes was undetectable (data not shown). Taken
together, these results suggest that ethanol-induced CYP2A6
expression is mediated by the oxidative stress resulting from
CYP2E1-dependent ethanol metabolism.
Ethanol-mediated CYP2A6 induction is attenuated by
vitamin C
To examine the role of ethanol-metabolism induced oxidative
stress in CYP2A6 expression, we treated the cells with 100 mM
antioxidant vitamin C. Vitamin C significantly inhibited induction
of CYP2A6 mRNA and protein by ethanol (Fig. 2A and B). As
expected, vitamin C also attenuated ethanol-induced oxidative
stress (Fig. 2C and D). These results suggested that ethanol-
induced CYP2A6 expression is mediated through oxidative stress.
Ethanol-induced CYP2A6 expression is mediated through
nuclear translocation of Nrf2
Since oxidative stress-mediated translocation of nuclear ery-
throid 2-related factor 2 (Nrf2) is known to induce antioxidant
genes, we tested whether this pathway is also involved in the
regulation of the CYP2A6 enzyme. Treatment with 100 mM BHA,
a stabilizer of Nrf2, enhanced CYP2A6 mRNA and protein levels
by .200% and .150%, respectively (Fig. 3A and B). As expected,
BHA also increased the level of Nrf2 in the nucleus at 12 and18 h
(Fig. 3C). The BHA treatment at .24 h led to increased cell death
(data not shown), which is consistent with a previous study that
100 mM BHA potentiates apoptosis after 24 h [20].
To further examine the role of Nrf2 in CYP2A6 induction,
U937 monocytes were pretreated with staurosporine, an inhibitor
of PKC that also inhibits translocation of Nrf2 into the nucleus.
Figure 3. Effect of 100 mM BHA on CYP2A6 and Nrf2 expression levels. (A) CYP2A6 mRNA. (B) CYP2A6 protein. (C) Nrf2 protein from nuclear
extracts. For each experiment, the mRNA/protein levels of various treatments were normalized relative to the untreated control, which has been set
to 100%. Blots are representative of at least three replicates. The mean 6 SD was calculated from at least triplicates and significance (p#0.05; *) was
determined using one-way ANOVA. The experiment was repeated twice.
doi:10.1371/journal.pone.0035505.g003
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protein induction (Fig. 4A and B). As expected, staurosporine also
decreased ethanol-induced Nrf2 expression in the nucleus
(Fig. 4C). Overall, these results suggest that CYP2A6 induction
is associated with increased translocation of Nrf2 into the nucleus.
Ethanol induces CYP2A6 by the activation of the MEK
pathway
To further investigate the signaling pathway(s) involved in
ethanol-mediated Nrf2 translocation into the nucleus and
CYP2A6 induction, we pretreated U937 monocytes using multiple
inhibitors of the oxidative stress-PKC mediated pathway. The
inhibitor of mitogen-activated protein kinase kinase (MEK),
U0126 [21], at 10 mM completely abolished ethanol-induced
nuclear Nrf2 expression, which was accompanied by decreased
expression of CYP2A6 at both mRNA and protein levels (Fig. 5A,
B and C). However, c-Jun N-terminal kinase (JNK) inhibitor,
SB600125, showed no effect on ethanol-induced nuclear Nrf2
expression and CYP2A6 induction (Fig. 5D).
Discussion
Although CYP2A6 metabolizes the clearance of several
xenobiotics, including nicotine, its induction by xenobiotics is
not well understood [3,5,6]. Recently we have shown that
CYP2A6 is induced by ethanol and it metabolizes nicotine into
cotinine and NNK, and this produces oxidative stress in U937 cells
[12,13]. In the current study, we show that CYP2A6 is induced by
increased oxidative stress mediated through ethanol metabolism
by CYP2E1 in U937 monocytes. Furthermore, we have shown
that the Nrf2 pathway, which is regulated by PKC and MEK, is
involved in CYP2A6 induction mediated by oxidative stress
(Fig. 6). Although the involvement of Nrf2 in CYP2A6 induction
in hepatic cells has recently been shown [22], this is the first report
to provide evidence that ethanol induces CYP2A6 through an
oxidative stress-mediated pathway that involves signaling through
PKC/MEK/Nrf2.
Although the increase in CYP2A6 expression resulting from a
single acute treatment of ethanol is 150–200%, it is significant
and these levels are consistent with previous reports using
hepatocytes [11,23], and U937 cells [13]. In this study we used
acute ethanol treatment to dissect the mechanism involved in
ethanol-mediated regulation CYP2A6 expression. However, it is
anticipated that chronic ethanol exposure would produce a
relatively greater increase in CYP2E1 expression that would lead
to higher levels of oxidative stress and CYP2A6 expression.
Indeed, our preliminary observations from human monocytes of
mild-to-moderate alcoholics have shown that CYP2E1 and
CYP2A6 are induced by ten and four fold, respectively (data not
shown), which is consistent with a previous study that evaluated
chronic exposure of liver and brain to alcohol and nicotine in rat
and monkey [24,25].
Recently it has been shown that rat CYP2A5 (homologous to
human CYP2A6) is induced by increased ROS generated from
ethanol metabolism, indicating the central role of oxidative stress
in regulating CYP2A5 [23]. A similar mechanism for CYP2A5
Figure 4. Effect of 10 nM staurosporine on ethanol-induced CYP2A6 and Nrf2 expression levels. (A) CYP2A6 mRNA. (B) CYP2A6 protein.
(C) Nrf2 protein from nuclear extracts. Both mRNA and protein expression levels were evaluated at 12 h in the presence of 100 mM ethanol (2/
+10 nM staurosporine 1 h prior to ethanol treatment). Blots are representative of at least three replicates. For each experiment, the mRNA/protein
levels of various treatments were normalized relative to the untreated control, which has been set to 100%. The mean 6 SD was calculated from at
least triplicates and significance (p#0.05; *) was determined using one-way ANOVA. The experiment was repeated three times.
doi:10.1371/journal.pone.0035505.g004
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oxidative stress [11]. In these studies, they demonstrated that
CYP2A5 induction by ethanol is dependent upon CYP2E1 which
metabolizes ethanol and produces ROS. In an independent study
with African green monkeys, pretreatment with ethanol elevated
nicotine toxicity, presumably through enhanced CYP2A6 expres-
sion and nicotine metabolism [25]. These findings are consistent
with our results that ethanol-induced oxidative stress by CYP2E1
is responsible for the induction of CYP2A6. The increased level of
CYP2A6 could further increase ROS and generate pre-carcino-
gens through CYP2A6-mediated nicotine metabolism and/or
activation of other tobacco constituents as has been demonstrated
in liver [26] and U937 monocytes [12].
Oxidative stress generated by BHA has been shown to induce
nuclear transcription factor Nrf2, leading to the induction of
antioxidants [27,28]. Consistent with a recent report [22], our
results demonstrate that CYP2A6 is induced by ethanol-mediated
oxidative stress that subsequently activates the Nrf2 pathway
(Fig. 6). An increase in ROS level in the cytoplasm releases Nrf2
from the Nrf2/Kelch-like ECH-associated protein 1(Keap1)
complex and the free Nrf2 is phosphorylated by PKC resulting
in translocation of Nrf2 from the cytoplasm to the nucleus [29,30].
The translocated Nrf2 binds antioxidant response elements (ARE)
and induces multiple antioxidant enzymes, such as phase II
enzymes, NAD(P)H quinone oxidoreductase 1, and glutathione S-
transferase (GST) [31,32]. Earlier studies have shown that the
nuclear translocation of Nrf2 and generation of antioxidants are
increased by alcohol, and function to ameliorate alcohol-induced
apoptotic death and liver toxicity [33,34]. Furthermore, the
Keap1/Nrf2/ARE signaling pathway has been shown to be
involved in suppression of nuclear factor kappa-light-chain-
enhancer of activated B cells (NF-kB) and its-mediated inflam-
matory effects [35]. Thus, the protective effect of Keap1/Nrf2/
ARE signaling contributes to the maintenance of cellular
homeostasis and the prevention of cell and tissue damage. As
ARE is a known ligand of AhR [36], Nrf2-mediated CYP2A6
expression may also be involved in the crosstalk between the
receptors AhR and PXR.
Staurosporine, which blocks the translocation of Nrf2 into the
nucleus, is known to bind PKC leading to the inhibition of
phosphorylation of MEK and JNK proteins [37]. Our results from
experiments with staurosporine or U0126 (MEK inhibitor) clearly
suggest that phosphorylation of MEK, but not JNK, regulates
Nrf2-mediated transcription of CYP2A6. It should be noted that
U0126 alone also increased the levels of CYP2A6 mRNA, but not
the levels of protein. In an earlier study it was shown that, in
addition to being a strong inhibitor of MEK, U0126 is also a weak
trans-activator of AhR, which binds to the xenobiotic response
element (XRE) and upregulates CYP1A enzymes [21]. Since the
XRE is common to the CYP1A and CYP2A6 enhancer/promoter
regions, U0126 may also induce and/or stabilize CYP2A6 mRNA
in the absence of ethanol. However, in the presence of ethanol,
Figure 5. Effect of 10 mM U0126 (MEK inhibitor), as well as 10 mM SB600125 (JNK inhibitor), on ethanol-induced CYP2A6 and Nrf2
expression levels. (A) CYP2A6 mRNA. (B) CYP2A6 protein. (C) Nrf2 protein from nuclear extracts. Both mRNA and protein expression levels were
evaluated at 12 h in the presence of 100 mM ethanol (2/+10 mM U0126 or SB600125 1 h prior to ethanol treatment). For each experiment, the
mRNA/protein levels of various treatments were normalized relative to the untreated control, which has been set to 100%. Blots are representative of
at least three replicates. The mean 6 SD was calculated from at least triplicates and significance (p#0.05; *) was determined using one-way ANOVA.
The experiment was repeated twice.
doi:10.1371/journal.pone.0035505.g005
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strong inhibitor of MEK, but a weak agonist of AhR.
The findings from our study suggest that ethanol-induced Nrf2
translocation into the nucleus that results into CYP2A6 induction
is mediated through the activation of PKC/MEK pathway. PKC
is known as a ‘‘stress sensor’’ and controls the functions of other
proteins via phosphorylation of MEK or JNK. Its activation is
involved in multiple signal transduction cascades and is associated
with the regulation of different cellular processes; such as, cell
growth, immune response, apoptosis, and necrosis [38]. PKC is
also known to be involved in alcohol-induced toxicity and liver
damage [39]. As the downstream signaling cascades of PKC, both
MEK and JNK, have been found to be activated by alcohol
leading to expression of antioxidant genes in HepG2 cells and
primary hepatocytes [40,41]. In contrast, other studies have shown
that PKC can also directly affect Nrf2 nuclear translocation and
regulate the expression of antioxidant genes in HepG2 cells [42–
44]. These contrasting findings suggest that the involvement of
MEK in PKC-mediated Nrf2 translocation is cell type dependent.
The finding of oxidative stress-mediated CYP2A6 expression by
ethanol in monocytes, which are known to secrete anti-
inflammatory cytokines and chemokines [45], is important
because of the potential for cross talk between CYP and cytokines.
In fact, ethanol has been shown to induce several cytokines in
monocytes, lymphocytes, and astrocytes [46]. Furthermore,
emerging studies from simultaneous expressions of CYPs and
cytokines [47], as well as the finding that IL-6 regulates CYP3A4,
suggest a cross talk between CYPs and cytokines [48]. This could
have important implications in the case of simultaneous exposure
to various xenobiotics, as well as bacterial or viral pathogens.
Therefore, it is imperative to further dissect the signaling pathway
that is responsible for the simultaneous induction of both CYP2A6
and cytokines by ethanol in monocytes.
Previously, lipid peroxidation has been observed in studies on
the effects of alcohol [49,50]. In addition, nicotine has been
reported to cause oxidative damage and to increase the
permeability of the blood-brain barrier [51]. Chronic accumula-
tion of ROS leads to over consumption of glutathione and
antioxidants, leading to cellular toxicity [52]. The use of
antioxidant supplements, such as vitamin C and E, has been
shown to be effective in attenuating the oxidative stress-mediated
effects of alcoholic liver disease [53]. Our findings suggest the
potential use of a CYP2E1 selective inhibitor [19] among alcohol
and tobacco users to reduce alcohol-mediated oxidative stress and
induction of CYP2A6 expression and activity, which can further
increase oxidative stress through nicotine metabolism. Our
argument is supported by the fact that a similar approach using
a selective CYP2A6 inhibitor is being considered to treat nicotine
dependence [54] and to prevent tobacco/nicotine-mediated lung
cancer [55].
In conclusion, the current study provides the first report of the
regulation of CYP2A6 expression by ethanol through activation of
the oxidative stress-mediated PKC/MEK/Nrf2 pathway in
monocytic cells (Fig. 6). This is a significant finding because
tobacco/nicotine has been shown to enhance HIV-1 replication in
alveolar macrophages and microglia [56,57], perhaps through
oxidative stress [58–60]. We speculate that ethanol-mediated
induction of CYP2A6 will increase the metabolism of nicotine
leading to an increase in oxidative stress and perhaps HIV-1
replication in HIV-infected individuals who consume both alcohol
and tobacco (Fig. 6). This line of investigation may have clinical
relevance because HIV-1 infected monocytes may infiltrate the
Figure 6. Schematic representation of oxidative stress-dependent Nrf2 translocation through PKC/MEK pathway leading to
induction of CYP2A6 by CYP2E1-mediated ethanol metabolism; the CYP2A6 induction can metabolize nicotine and further
increase ROS formation. DAS: Diallyl sulfide; ROS: Reactive oxygen species; BHA: Butylated hydroxyanisole; MAPK: Mitogen-activated protein
kinase; PKC: Protein kinase C; MEK: Mitogen-activated kinase kinase, Nrf2: Nuclear factor-erythroid2-related factor 2; Erk1: Extracellular signal-
regulated kinases; JNK: c-Jun N-terminal kinase; ARE: Antioxidant response element; XRE: Xenobiotic response element; TRE: 12-O-
tetradecanoylphorbol-13-acetate response element.
doi:10.1371/journal.pone.0035505.g006
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Further, since the prevalence of smoking is 3 times higher among
alcoholics, especially among HIV-infected individuals, this finding
has important implications for HIV+ alcohol/tobacco co-abusers.
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